Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Flex Pharma Inc (FLKS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,426
  • Shares Outstanding, K 18,069
  • Annual Sales, $ 840 K
  • Annual Income, $ -21,920 K
  • 60-Month Beta 1.80
  • Price/Sales 8.86
  • Price/Cash Flow N/A
  • Price/Book 1.02
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.88
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/01/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.39 +7.15%
on 05/13/19
0.60 -30.53%
on 04/24/19
-0.10 (-19.85%)
since 04/17/19
3-Month
0.31 +34.45%
on 03/07/19
0.76 -45.16%
on 04/15/19
+0.06 (+15.78%)
since 02/15/19
52-Week
0.26 +60.31%
on 12/24/18
4.30 -90.31%
on 06/11/18
-3.35 (-88.94%)
since 05/17/18

Most Recent Stories

More News
Flex Pharma: 1Q Earnings Snapshot

BOSTON (AP) _ Flex Pharma Inc. (FLKS) on Wednesday reported a loss of $2.2 million in its first quarter.

FLKS : 0.42 (+1.41%)
Flex Pharma Reports First Quarter 2019 Financial Results

Flex Pharma, Inc. (NASDAQ: FLKS), today announced its financial results for the three months ended March 31, 2019.

FLKS : 0.42 (+1.41%)
Look for Shares of Flex Pharma Inc to Potentially Pullback after Yesterday's 8.84% Rise

Flex Pharma Inc (NASDAQ:FLKS) traded in a range yesterday that spanned from a low of $0.60 to a high of $0.68. Yesterday, the shares gained 8.8%, which took the trading range above the 3-day high of...

FLKS : 0.42 (+1.41%)
Lifshitz & Miller LLP Announces Investigation of AmpliPhi Biosciences Corporation, Churchill Capital Corporation, DaVita Inc., Flex Pharma, Inc., MYnd Analytics, Inc., SunCoke Energy Partners, L.P., Top Image Systems Ltd., and Uniti Financial Corporation

AmpliPhi Biosciences Corporation (APHB)

CCC : 13.35 (-0.15%)
TISA : 0.85 (unch)
SXCP : 11.18 (+1.36%)
MYND : 1.17 (-4.10%)
APHB : 0.32 (-20.33%)
DVA : 49.23 (-1.54%)
FLKS : 0.42 (+1.41%)
SXC : 7.87 (+1.42%)
Flex Pharma Reports Fourth Quarter and Fiscal 2018 Financial Results

Flex Pharma, Inc. (NASDAQ: FLKS), today announced its financial results for the three months and fiscal year ended December 31, 2018.

FLKS : 0.42 (+1.41%)
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Flex Pharma, Inc. - FLKS

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating the Board of Directors...

FLKS : 0.42 (+1.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade FLKS with:

Business Summary

Flex Pharma, Inc. is a biotechnology company. The Company is involved in developing treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions. Flex Pharma, Inc. is headquartered in Boston, Massachusetts.

See More

Key Turning Points

2nd Resistance Point 0.45
1st Resistance Point 0.43
Last Price 0.42
1st Support Level 0.40
2nd Support Level 0.39

See More

52-Week High 4.30
Fibonacci 61.8% 2.76
Fibonacci 50% 2.28
Fibonacci 38.2% 1.80
Last Price 0.42
52-Week Low 0.26

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar